Solvonis TherapeuticsLSE:SVNS +5.00% Median PS Value is £0.00 as of Jul. 05, 2026. The stock has 4 warning signs investors should review. Among 1,642 Industrial Products companies, Solvonis Therapeutics ranks worse than 60901.28% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Solvonis Therapeutics's Median PS Value or its related term are showing as below:
LSE:SVNS's Price-to-Median-PS-Value is not ranked *
in the Industrial Products industry.
Industry Median: 1.14 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Solvonis Therapeutics (LSE:SVNS) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Solvonis Therapeutics's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.00168
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solvonis Therapeutics Median PS Value Related Terms
Solvonis Therapeutics Median PS Value Historical Data
* Premium members only.
The historical data trend for Solvonis Therapeutics's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:SVNS vs GEV, ETN, PH: Median PS Value Comparison
For the Specialty Industrial Machinery subindustry, Solvonis Therapeutics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solvonis Therapeutics Price-to-Median-PS-Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Solvonis Therapeutics's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Solvonis Therapeutics's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is .
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Solvonis Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was £0.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solvonis Therapeutics (LSE:SVNS) has a Median PS Value of £0.00 as of Jul. 05, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Solvonis Therapeutics and its competitors. According to the industry distribution chart, Solvonis Therapeutics ranks #999999 out of 1642 companies in the Industrial Products industry.
Is Solvonis Therapeutics' Median PS Value too high?
Solvonis Therapeutics' current Median PS Value is £0.00. Based on the distribution chart, Solvonis Therapeutics ranks #999999 out of 1642 companies in the Industrial Products industry, which is in the bottom quartile relative to peers.
How does Solvonis Therapeutics' Median PS Value compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Solvonis Therapeutics ranks #999999 out of 1642 companies for Median PS Value. This places Solvonis Therapeutics in the lower half of its industry. The industry median Median PS Value is 1.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for an Industrial Products company?
The median Median PS Value among Industrial Products companies is 1.14, based on 1,642 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Solvonis Therapeutics and its competitors. For the Industrial Products industry, the median Median PS Value is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solvonis Therapeutics's current Median PS Value is £0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solvonis Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Solvonis Therapeutics (LSE:SVNS) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.00 — trading 91.6% below its estimated fair value. The current Median PS Value is £0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Solvonis Therapeutics (LSE:SVNS), the current Median PS Value is £0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Solvonis Therapeutics PLC focuses on the development of therapeutic solutions. The company is engaged in the development of novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders focusing on addiction and psychiatry. The products in company's pipeline include SVN-001, SVN-002, SVN-015. SVN-114, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:SVNS has been successfully added to your 